KIDRON NADAV 4

What Happened
Nadav Kidron, President, CEO and director of Oramed Pharmaceuticals (ORMP), disposed of 100,000 shares on 2026-03-12 as a gift. The reported transaction price is $0.00 and the total proceeds received were $0. This was a charitable donation (transaction code G), not an open-market sale.

Key Details

• Transaction date: 2026-03-12; reported on Form 4 filed 2026-03-16 (timely within two business days).
• Amount: 100,000 shares disposed; reported price per share: $0.00 (no market price because this was a gift).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (F1): The shares were donated to charity, no value was received, and the reporting person has no affiliation with or control over the donee.
• Filing timeliness: Filed 2026-03-16 for a 2026-03-12 transaction — consistent with timely Form 4 reporting.

Context
Gifts of shares are charitable or personal transactions and do not represent a market sale or a direct signal of the insider’s view of the company’s stock price. For retail investors, purchases by insiders typically provide stronger actionable signals; donations mainly indicate a transfer of ownership without cash proceeds.